| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.2 | 0.0006 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.002 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.23 | 0.002 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.094 | 0.006 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.006 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.009 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.01 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.078 | 0.01 |